SCHEMBL9530052

SCHEMBL9530052

CC/C=C/c1nc(OCCC)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.35
AGTR2 P50052 4/20 0.35
PDE5A O76074 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530060 1.00 AGTR1 (0.35) AGTR1AGTR2PDE5A
SCHEMBL9528088 0.93 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9528094 0.93 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9529532 0.90 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9529541 0.90 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL8109435 0.86 AGTR1 (0.39) AGTR1AGTR2PDE5A
SCHEMBL8105591 0.85 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL8105593 0.85 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL8096094 0.85 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL8096088 0.85 AGTR1 (0.44) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed